These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1875236)

  • 1. Transient state kinetic studies on catalysis and inhibition of staphylococcal beta-lactamase.
    Virden R
    J Chemother; 1991 Apr; 3(2):79-82. PubMed ID: 1875236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-lactamase stability of amoxycillin with the beta-lactamase inhibitor, clavulanic acid.
    Reading C; Farmer T; Cole M
    J Antimicrob Chemother; 1983 Jan; 11(1):27-32. PubMed ID: 6600741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content.
    Kitzis MD; Gutmann L; Acar JF
    J Antimicrob Chemother; 1985 Jan; 15(1):23-30. PubMed ID: 3882654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ; Jin YF; Turner HL
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-pyrrylderivatives of penicillins. Kinetics and inhibition studies with clavulanic acid of a Bacillus cereus beta-lactamase.
    Díez MT; Arín MJ; Negro A; Salto F
    Pharmazie; 1987 Jun; 42(6):415-6. PubMed ID: 3118398
    [No Abstract]   [Full Text] [Related]  

  • 6. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid.
    Thomson CJ; Amyes SG
    J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
    Cuffini AM; De Renzi G; Tullio V; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1996; 22(1):9-15. PubMed ID: 8839632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric studies on the inhibition of TEM-2 beta-lactamase by clavulanic acid derivatives.
    Brown RP; Aplin RT; Schofield CJ; Frydrych CH
    J Antibiot (Tokyo); 1997 Feb; 50(2):184-5. PubMed ID: 9099233
    [No Abstract]   [Full Text] [Related]  

  • 9. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
    Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
    Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of beta-lactamase inhibitors.
    Sutherland R
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of piperacillin and ticarcillin from beta-lactamase hydrolysis by tazobactam (YTR-830) and clavulanic acid.
    Diver JM; Thornber D; Wise R
    J Antimicrob Chemother; 1989 Jul; 24(1):89-92. PubMed ID: 2550415
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview.
    Matagne A; Ghuysen MF; Frère JM
    Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):705-11. PubMed ID: 8240281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compounds.
    Galleni M; Franceschini N; Quinting B; Fattorini L; Orefici G; Oratore A; Frère JM; Amicosante G
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1608-14. PubMed ID: 7979294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of beta-lactamase inhibitors.
    Rolinson GN
    Surg Gynecol Obstet; 1991; 172 Suppl():11-6. PubMed ID: 2024221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of Aeromonas hydrophila to beta-lactam antibiotics.
    Zemelman R; Gonzalez C; Mondaca MA; Silva J; Merino C; Dominguez M
    J Antimicrob Chemother; 1984 Dec; 14(6):575-9. PubMed ID: 6335147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of beta-lactamase inhibitors.
    Rolinson GN
    Rev Infect Dis; 1991; 13 Suppl 9():S727-32. PubMed ID: 1656513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of beta-lactamase-producing bacteria.
    Sutherland R
    Scott Med J; 1982; 27 Spec No.():S3-9. PubMed ID: 6984779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins.
    Mariotte-Boyer S; Nicolas-Chanoine MH; Labia R
    FEMS Microbiol Lett; 1996 Sep; 143(1):29-33. PubMed ID: 8807798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between beta-lactamase activity and resistance to beta-lactam antibiotics in Mycobacterium smegmatis.
    Yabu K; Kaneda S; Ochiai T
    Microbiol Immunol; 1985; 29(9):803-9. PubMed ID: 3877858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.